Showing results (21-30 of 107) with videos related to
Sort By:
Pageof 11
BMC Health Services Research|December 30, 2024
Development and validation of the Chinese patient-centered integrated care scaleYue Yin, Wenqing Gao, Xiujuan Cui, et al.Frontiers in Oncology|July 25, 2024
Comparison of systemic treatments for previously treated patients with unresectable colorectal liver metastases: a systematic review and network meta-analysisYunlin Jiang, Mingye Zhao, Wenxi Tang, et al.BMC Cancer|February 9, 2024
Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysisYunlin Jiang, Mingye Zhao, Wenxi Tang, et al.Circulation Research|June 4, 2026
Antibody E06 and the Role of Oxidized Phospholipids in Atherogenesis and InflammationJoseph L Witztum, Xuchu Que, Wenxi Tang, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015Wenxi Tang, Jing Xie, Fanxin Kong, et al.International Journal of Environmental Research and Public Health|May 28, 2022
Transition from Nurses to Medicalized Elderly Caregivers: Comparison on Willingness between Traditional and Modern Regions in ChinaWenqing Gao, Shuailong Li, Zhuoyuan Chi, et al.BMC Health Services Research|July 25, 2019
Impact of public hospital pricing reform on medical expenditure structure in Jiangsu, China: a synthetic control analysisXiao Zang, Mengran Zhang, Shihao Wei, et al.Research Synthesis Methods|February 2, 2026
NMAsurv: An R Shiny application for network meta-analysis based on survival dataTaihang Shao, Mingye Zhao, Fenghao Shi, et al.BMC Cancer|February 8, 2024
Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysisMingye Zhao, Taihang Shao, Hanqiao Shao, et al.Cost Effectiveness and Resource Allocation : C/E|May 13, 2026
Comparative effectiveness and cost-effectiveness of ALK-positive NSCLC sequential strategies under physician and patient preferencesHao Li, Mingye Zhao, Yue Yin, et al.Pageof 11